Multivariable analysis of association of beta-blocker use and survival in advanced ovarian cancer.

CONCLUSION: In this retrospective study, we found that patients identified as being on a beta-blocker at the time of surgery had worse overall survival and greater risk of death when compared to those patients not on betablockers. Importantly, 90% of patients on beta-blockers were identified as being on a cardioselective beta-blocker.
PMID: 32222327 [PubMed - as supplied by publisher]

Source: Gynecologic Oncology - March 24, 2020 Category: Cancer & Oncology Authors: Gonzalez R, Gockley AA, Melamed A, Sugrue R, Clark RM, Del Carmen MG, Growdon W, Berkowitz RS, Horowitz NS, Worley MJ Tags: Gynecol Oncol Source Type: research